Impact of rhinitis on asthma control in children: Association with FeNO

Journal of Asthma

Volumn 47, Issue 6, 2010, Pages 604-608

  Chiron, Raphael ^a   Vachier, Isabelle ^a   Khanbabaee, Ghamartaj ^a   Molinari, Nicolas ^b   Varrin, Muriel ^c   Godard, Philippe ^a   Chanez, Pascal ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b NÎMES UNIVERSITY HOSPITAL   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

Atopy; Nitric oxide; Rhinitis score; Upper airways

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; ASTHMA CONTROL; CHEMOLUMINESCENCE; CHILD; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE PREDISPOSITION; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; RHINITIS; SPIROMETRY; SYMPTOM;

ADOLESCENT; ASTHMA; BREATH TESTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NITRIC OXIDE; RHINITIS; SPIROMETRY; STATISTICS, NONPARAMETRIC;

EID: 77955537680     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770901003759402     Document Type: Article

References (32)

1. Woolcock AJ, Peat JK. Evidence for the increase in asthma worldwide. Ciba Found Symp 1997; 206:122-134.
2. Agence Nationale dAccréditation et d ́ Evaluation en Santé, Recommandations pour le suivi médical des patients asthmatiques adultes et adolescents Available at: http://www.has-sante.fr/ (2004).
3. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 2004; 170:836-844.
4. Gustafsson PM, Watson L, Davis KJ, Rabe KF. Poor asthma control in children: evidence from epidemiological surveys and implications for clinical practice. Int J Clin Pract 2006; 60:321-334.
5. Peroni DG, PiacentiniGL, Ceravolo R, BonerAL. Difficult asthma: possible association with rhinosinusitis. Pediatr Allergy Immunol 2007; 18(Suppl 18):25-27.
6. Lundback B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998; 28(Suppl 2):3-10.
7. Ragab S, Scadding GK, Lund VJ, Saleh H. Treatment of chronic rhinosinusitis and its effects on asthma. Eur Respir J 2006; 28:68-74.
8. Lai L, Hopp RJ, Lusk RP. Pediatric chronic sinusitis and asthma: a review. J Asthma 2006; 43:719-725.
9. Juniper EF, OByrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-907.
10. van Dellen QM, Stronks K, Bindels PJ, Ory FG, van Aalderen WM. Adherence to inhaled corticosteroids in children with asthma and their parents. Respir Med 2008; 102:755-763.
11. Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 2004; 114:1241-1256.
12. Buchvald F, Baraldi E, Carraro S, Gaston B, De Jongste J, Pijnenburg MW, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol 2005; 115:1130-1136.
13. Kharitonov SA, Walker L, Barnes PJ. Repeatability of standardised nasal nitric oxide measurements in healthy and asthmatic adults and children. Respir Med 2005; 99:1105-1114.
14. Quanjer PH, Stocks J, Polgar G,Wise M, Karlberg J, Borsboom G. Compilation of reference values for lung function measurements in children. Eur Respir J Suppl 1989;4:184S-261S.
15. Annesi-Maesano I. Epidemiological evidence of the occurrence of rhinitis and sinusitis in asthmatics. Allergy 1999; 54(Suppl 57):7-13.
16. Lombardi E, Stein RT, Wright AL, MorganWJ, Martinez FD. The relation between physician-diagnosed sinusitis, asthma, and skin test reactivity to allergens in 8-year-old children. Pediatr Pulmonol 1996; 22:141-146.
17. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368:733-743.
18. Choi SH, Kim do K, Yoo Y, Yu J, Koh YY. Comparison of deltaFVC between patients with allergic rhinitis with airway hypersensitivity and patients with mild asthma. Ann Allergy Asthma Immunol 2007; 98:128-133.
19. Sole D, Camelo-Nunes IC,Wandalsen GF, Melo KC,Naspitz CK. Is rhinitis alone or associated with atopic eczema a risk factor for severe asthma in children? Pediatr Allergy Immunol 2005; 16:121-125.
20. Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D. Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics 2005; 115:129-134. (Pubitemid 43046291)
21. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002; 109:636-642.
22. Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy 2006; 61: 717-724.
23. Bousquet J, Vignola AM, Campbell AM, Michel FB. Pathophysiology of allergic rhinitis. Int Arch Allergy Immunol 1996; 110:207-218.
24. Togias A. Mechanisms of nose-lung interaction. Allergy 1999; 54 Suppl 57:94-105.
25. de Benedictis FM, del Giudice MM, Severini S, Bonifazi F. Rhinitis, sinusitis and asthma: one linked airway disease. Paediatr Respir Rev 2001; 2:358-364
26. Aronsson D, Tufvesson E, Bjermer L. Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide. Clin Exp Allergy 2005; 35:1457-1461.
27. Cardinale F, de Benedictis FM, Muggeo V, Giordano P, Loffredo MS, Iacoviello G, et al. Exhaled nitric oxide, total serum IgE and allergic sensitization in childhood asthma and allergic rhinitis. Pediatr Allergy Immunol 2005; 16:236-242.
28. Heffler E, Guida G, Marsico P, Bergia R, Bommarito L, Ferrero N, et al. Exhaled nitric oxide as a diagnostic test for asthma in rhinitic patients with asthmatic symptoms. Respir Med 2006; 100:1981-1987.
29. Eby GA. Strong humming for one hour daily to terminate chronic rhinosinusitis in four days: a case report and hypothesis for action by stimulation of endogenous nasal nitric oxide production. Med Hypotheses 2006; 66:851-854.
30. Moody A, Fergusson W, Wells A, Bartley J, Kolbe J. Nasal levels of nitric oxide as an outcome variable in allergic upper respiratory tract disease: Influence of atopy and hayfever on nNO. Am J Rhinol 2006; 20: 425-429.
31. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9:687-695.
32. Bousquet J, Khaltaev N, Cruz AA, Denburg J, FokkensWJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with theWorld Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(Suppl 86):8-160. (Pubitemid 351357811)